标题
MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 17, Pages 6202
出版商
MDPI AG
发表日期
2020-08-27
DOI
10.3390/ijms21176202
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Beyond antibiotics for pulmonary nontuberculous mycobacterial disease
- (2020) Grant Waterer CURRENT OPINION IN PULMONARY MEDICINE
- Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus
- (2020) Matt D. Johansen et al. NATURE REVIEWS MICROBIOLOGY
- Macrophage Signaling Pathways in Pulmonary Nontuberculous Mycobacteria Infections
- (2020) Zohra Prasla et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Identification and drug susceptibility testing for nontuberculous mycobacteria
- (2020) Wei-Chang Huang et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- New tuberculosis drug targets, their inhibitors, and potential therapeutic impact
- (2020) Gauri S. Shetye et al. Translational Research
- Structure‐Based Design and Synthesis of Piperidinol‐Containing Molecules as New Mycobacterium abscessus Inhibitors
- (2020) Jérôme Ruyck et al. ChemistryOpen
- Potency Increase of Spiroketal Analogs of Membrane Inserting Indolyl Mannich Base Antimycobacterials Is Due to Acquisition of MmpL3 Inhibition
- (2020) Ming Li et al. ACS Infectious Diseases
- Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary
- (2020) Charles L Daley et al. CLINICAL INFECTIOUS DISEASES
- Direct Inhibition of MmpL3 by Novel Antitubercular Compounds
- (2019) Wei Li et al. ACS Infectious Diseases
- Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II
- (2019) Wei Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis
- (2019) Nakwon Kwak et al. EUROPEAN RESPIRATORY JOURNAL
- Crystal Structures of Membrane Transporter MmpL3, an Anti-TB Drug Target
- (2019) Bing Zhang et al. CELL
- Advancing the therapeutic potential of indoleamides for tuberculosis
- (2019) Shichun Lun et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- MmpL3 is a lipid transporter that binds trehalose monomycolate and phosphatidylethanolamine
- (2019) Chih-Chia Su et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chemical disarming of isoniazid resistance in Mycobacterium tuberculosis
- (2019) Kelly Flentie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 1H-benzo[d]imidazole derivatives affect MmpL3 in Mycobacterium tuberculosis
- (2019) Małgorzata Korycka-Machała et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bedaquiline Eliminates Bactericidal Activity of β-Lactams against Mycobacterium abscessus
- (2019) Marissa Lindman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimycobacterial Susceptibility Testing of Nontuberculous Mycobacteria
- (2019) Barbara A. Brown-Elliott et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The MmpL3 interactome reveals a complex crosstalk between cell envelope biosynthesis and cell elongation and division in mycobacteria
- (2019) Juan Manuel Belardinelli et al. Scientific Reports
- Editorial: NTM—The New Uber-Bugs
- (2019) Veronique Dartois et al. Frontiers in Microbiology
- Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance
- (2019) John T. Williams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Pyrazole-Containing Compounds Active against Mycobacterium tuberculosis
- (2019) Giovanna Poce et al. ACS Medicinal Chemistry Letters
- Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients
- (2019) Degiacomi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A piperidinol-containing molecule is active against Mycobacterium tuberculosis by inhibiting the mycolic acid flippase activity of MmpL3
- (2019) Christian Dupont et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of novel scaffolds targeting Mycobacterium tuberculosis
- (2019) Michael Dal Molin et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The mycobacterial cell envelope — a moving target
- (2019) Charles L. Dulberger et al. NATURE REVIEWS MICROBIOLOGY
- Electrochemistry of ring-substituted 1-hydroxynaphthalene-2-carboxanilides: Relation to structure and biological activity
- (2019) Július Gajdár et al. ELECTROCHIMICA ACTA
- Active Benzimidazole Derivatives Targeting the MmpL3 Transporter in Mycobacterium abscessus
- (2019) Clément Raynaud et al. ACS Infectious Diseases
- Rifabutin acts in synergy and is bactericidal with frontline Mycobacterium abscessus antibiotics clarithromycin and tigecycline, suggesting a potent treatment combination
- (2018) Mark Pryjma et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- HC2091 Kills Mycobacterium tuberculosis by Targeting the MmpL3 Mycolic Acid Transporter
- (2018) Huiqing Zheng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- NTM drug discovery: status, gaps and the way forward
- (2018) Mu-Lu Wu et al. DRUG DISCOVERY TODAY
- Indolyl Azaspiroketal Mannich Bases Are Potent Antimycobacterial Agents with Selective Membrane Permeabilizing Effects and in Vivo Activity
- (2018) Samuel Agyei Nyantakyi et al. JOURNAL OF MEDICINAL CHEMISTRY
- NonTuberculous Mycobacteria infection and lung transplantation in cystic fibrosis: a worldwide survey of clinical practice
- (2018) Adrien Tissot et al. BMC Pulmonary Medicine
- MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections
- (2018) Wei Li et al. Frontiers in Microbiology
- Discovery of benzothiazole amides as potent antimycobacterial agents
- (2018) James Graham et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors
- (2018) Chao Fang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Optimization and Lead Selection of Benzothiazole Amide Analogs Toward a Novel Antimycobacterial Agent
- (2018) Mary A. De Groote et al. Frontiers in Microbiology
- A description of Mycobacterium chelonae subsp. gwanakae subsp. nov., a rapidly growing mycobacterium with a smooth colony phenotype due to glycopeptidolipids
- (2018) Byoung-Jun Kim et al. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
- Novel Acetamide Indirectly Targets Mycobacterial Transporter MmpL3 by Proton Motive Force Disruption
- (2018) Annanya Shetty et al. Frontiers in Microbiology
- Disinfectant Susceptibility Profiling of Glutaraldehyde-Resistant Nontuberculous Mycobacteria
- (2017) Winona Burgess et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- The new phylogeny of the genus Mycobacterium : The old and the news
- (2017) Enrico Tortoli et al. INFECTION GENETICS AND EVOLUTION
- Targeting Mycolic Acid Transport by Indole-2-carboxamides for the Treatment of Mycobacterium abscessus Infections
- (2017) Alan P. Kozikowski et al. JOURNAL OF MEDICINAL CHEMISTRY
- Amphiphilic Indole Derivatives as Antimycobacterial Agents: Structure–Activity Relationships and Membrane Targeting Properties
- (2017) Tianming Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- MmpL3 is the flippase for mycolic acids in mycobacteria
- (2017) Zhujun Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reversion of antibiotic resistance inMycobacterium tuberculosisby spiroisoxazoline SMARt-420
- (2017) Nicolas Blondiaux et al. SCIENCE
- Genomic Insight into Mechanisms of Reversion of Antibiotic Resistance in Multidrug Resistant Mycobacterium tuberculosis Induced by a Nanomolecular Iodine-Containing Complex FS-1
- (2017) Aleksandr I. Ilin et al. Frontiers in Cellular and Infection Microbiology
- Screening of TB Actives for Activity against Nontuberculous Mycobacteria Delivers High Hit Rates
- (2017) Jian Liang Low et al. Frontiers in Microbiology
- Essentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression
- (2017) Giulia Degiacomi et al. Scientific Reports
- Tigecycline Potentiates Clarithromycin Activity against Mycobacterium avium In Vitro
- (2016) Hannelore I. Bax et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3
- (2016) Wei Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Progression and Treatment Outcomes of Lung Disease Caused byMycobacterium abscessusandMycobacterium massiliense
- (2016) Jimyung Park et al. CLINICAL INFECTIOUS DISEASES
- Mycobacterial Characteristics and Treatment Outcomes inMycobacterium abscessusLung Disease
- (2016) Won-Jung Koh et al. CLINICAL INFECTIOUS DISEASES
- Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection
- (2016) Jozef Stec et al. JOURNAL OF MEDICINAL CHEMISTRY
- A new piperidinol derivative targeting mycolic acid transport inMycobacterium abscessus
- (2016) Christian Dupont et al. MOLECULAR MICROBIOLOGY
- Structure of the Essential Mtb FadD32 Enzyme: A Promising Drug Target for Treating Tuberculosis
- (2016) Misty L. Kuhn et al. ACS Infectious Diseases
- Structure–Function Profile of MmpL3, the Essential Mycolic Acid Transporter from Mycobacterium tuberculosis
- (2016) Juan Manuel Belardinelli et al. ACS Infectious Diseases
- Risk Factors for Recurrence after Successful Treatment of Mycobacterium avium Complex Lung Disease
- (2015) Bo Young Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin
- (2015) Beatriz E. Ferro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues
- (2015) Katarzyna Gobis et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Nontuberculous Mycobacteria in Cystic Fibrosis and Non–Cystic Fibrosis Bronchiectasis
- (2015) In Park et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Novel Insights into the Mechanism of Inhibition of MmpL3, a Target of Multiple Pharmacophores in Mycobacterium tuberculosis
- (2014) Wei Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mycolic Acids: Structures, Biosynthesis, and Beyond
- (2014) Hedia Marrakchi et al. CHEMISTRY & BIOLOGY
- New Approaches to Target the Mycolic Acid Biosynthesis Pathway for the Development of Tuberculosis Therapeutics
- (2014) E. North et al. CURRENT PHARMACEUTICAL DESIGN
- N-Arylalkylbenzo[d]thiazole-2-carboxamides as anti-mycobacterial agents: design, new methods of synthesis and biological evaluation
- (2014) Parth Shah et al. MedChemComm
- Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis
- (2013) Lluís Ballell et al. ChemMedChem
- Preliminary Structure–Activity Relationships and Biological Evaluation of Novel Antitubercular Indolecarboxamide Derivatives Against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains
- (2013) Oluseye K. Onajole et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides: A Promising Class of Antituberculosis Agents
- (2013) Ravinder Reddy Kondreddi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis
- (2013) Regina Wilson et al. Nature Chemical Biology
- Improved BM212 MmpL3 Inhibitor Analogue Shows Efficacy in Acute Murine Model of Tuberculosis Infection
- (2013) Giovanna Poce et al. PLoS One
- Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3
- (2013) Modesto J. Remuiñán et al. PLoS One
- Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32
- (2013) S. A. Stanley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis
- (2013) S. P. S. Rao et al. Science Translational Medicine
- Indoleamides are active against drug-resistant Mycobacterium tuberculosis
- (2013) Shichun Lun et al. Nature Communications
- Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening
- (2012) Sarah A. Stanley et al. ACS Chemical Biology
- SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis
- (2012) Kapil Tahlan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane
- (2012) Anna E Grzegorzewicz et al. Nature Chemical Biology
- Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis
- (2012) Claire Andréjak et al. THORAX
- Investigations of genotoxic activity of antimicrobial/antiviral agent FS-1 in human lymphocytes and tumor cell
- (2011) A. Nersesyan et al. Cytology and Genetics
- Bacterial Growth and Cell Division: a Mycobacterial Perspective
- (2008) E. C. Hett et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started